Estimating the Effect of Influenza Vaccination on Nursing Home Residents' Morbidity and Mortality.

Pop-Vicas A, Rahman M, Gozalo PL, Gravenstein S, Mor V. Estimating the Effect of Influenza Vaccination on Nursing Home Residents' Morbidity and Mortality. Journal of the American Geriatrics Society. 2015 Sep 1; 63(9):1798-804.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

OBJECTIVES: To estimate the effect of influenza vaccination on hospitalization and mortality in nursing home (NH) residents. DESIGN: Retrospective cohort study. SETTING: Medicare claims data linked to NH Minimum Data Set assessments and Centers for Disease Control and Prevention (CDC) surveillance data from 122 U.S. cities. PARTICIPANTS: More than 1 million Medicare fee-for-service, long-stay NH residents between 2000 and 2009. MEASUREMENTS: Weekly facility outcome aggregates of NH resident pneumonia and influenza (PandI) hospitalizations and all-cause mortality and city-level PandI mortality as reported by the CDC were created. The seasonal vaccine match rate for influenza A/H1N1, A/H3N2, and B strains was calculated, and each outcome was compared in seasons of high and low match rates using facility fixed-effects regression models separately for full-year and nonsummer months. RESULTS: Average weekly all-cause mortality varied across seasons from 3.74 to 4.13 per 1,000 NH residents per week, and hospitalization for PandI varied from 2.05 to 2.43. Vaccine match rates were invariably high for H1N1 but variable across seasons for the other two types. The association between vaccine match and reduction in overall mortality and PandI hospitalizations was strongest for A/H3N2, the influenza strain typically responsible for the most-severe influenza cases. Given the approximately 130,000 deaths and 77,000 PandI hospitalizations of long-stay NH residents during the 32 nonsummer weeks, the model estimated that a 50-percentage-point increase in the A/H3N2 match rate (from < 25% to > 75%) reduced long-stay NH resident deaths by 2.0% and PandI hospitalizations by 4.2%. CONCLUSION: Well-matched influenza vaccine prevents PandI hospitalizations and mortality in NH residents.